22.418 articles found

[Ablative strategy: a definite treatment for cardiac arrhythmias?].

Hocini M, Pasquié JL, Jaïs P, Haïssaguerre M.

Rev Prat · 2004-02-01

PMID: 15134237

Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice.

Hinerfeld D, Traini MD, Weinberger RP, Cochran B, Doctrow SR, Harry J, Melov S.

J Neurochem · 2004-02-01

DOI: 10.1046/j.1471-4159.2003.02195.xPMID: 14720215

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE AND OTHER A-SYNUCLEINOPATHIES

MOURADIAN M MARAL, JUNN EUNSUNG.

· 2004-01-30

Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.

Kahl KG, Hagenah J, Zapf S, Trillenberg P, Klein C, Lencer R.

Psychopharmacology (Berl) · 2004-01-28

DOI: 10.1007/s00213-004-1803-0PMID: 14747903

Localized striatal delivery of GDNF as a treatment for Parkinson disease.

Kirik D, Georgievska B, Björklund A.

Nat Neurosci · 2004-01-27

DOI: 10.1038/nn1175PMID: 14747832

Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases

BORA KEENAN MARTIN, HU LAIN-YEN, KESTEN SUZANNE ROSS, LEI HUANYSHU, MORELAND DAVID WINSLOW, RAFFERTY MICHAEL FRANCIS, RYDER TODD ROBERT, SCHOLTEN JEFFREY DAVID, WUSTROW DAVID JUERGEN.

· 2004-01-26

Isoxazolopyridinones and use thereof in the treatment of parkinson's disease.

HINTERMANN SAMUEL, HENGERER BASTIAN, KROSIGK ULRIKE VON.

· 2004-01-23

Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases

CASTILLO GERARDO M, CHOI PAULA Y, SNOW ALAN D.

· 2004-01-21

DRUG PREPARATION COMPRISING A-LIPOIC ACID, AMBROXOL AND/OR INHIBITORS OF THE ANGIOTENSIN-CONVERTING ENZYME (ACE) AND ITS USE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

ROEHNERT PETER, ANSORGE SIEGFRIED, REYMANN KLAUS, STRIGGOW FRANK, TAEGER MICHAEL, SCHROEDER ULRICH.

· 2004-01-16

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

WEINER David M., DAVIS Robert E., BRANN Mark R..

· 2004-01-15

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

WEINER M.DAVID, DAVIS ROBERT E, BRANN MARK R, NASH NORMAN, ANDERSSON CARL-MAGNUS A, ULDAM ALLAN K.

· 2004-01-15

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

WEINER DAVID M, DAVIS ROBERT E, BRANN MARK R, ANDERSSON CARL-MAGNUS A, ULDAM ALLAN K.

· 2004-01-15